File Download

There are no files associated with this item.

Supplementary

Conference Paper: Incidence and clinical characteristics of hepatocellular carcinoma in chronic hepatitis B patients treated for up to 4 years with tenofovir alafenamide or tenofovir disoproxil fumarate in 2 large phase 3 studies.

TitleIncidence and clinical characteristics of hepatocellular carcinoma in chronic hepatitis B patients treated for up to 4 years with tenofovir alafenamide or tenofovir disoproxil fumarate in 2 large phase 3 studies.
在2项大型3期研究中，使用丙酚替诺福韦 (TAF)或富马酸替诺福韦二吡呋酯(TDF)治疗长达4年的慢性乙型肝炎(CHB)患者中肝细胞癌(HCC)的发生率和临床特征
Authors
Seto, WKW
Issue Date2019
Citation
The 10th National Conference of China Network for Severe Liver Disease (CNSLD), Suzhou, China, 16-18 May 2019 How to Cite?
Description分会场4: 肝胆相照发展论坛--论文交流
Persistent Identifierhttp://hdl.handle.net/10722/272421

 

DC FieldValueLanguage
dc.contributor.authorSeto, WKW-
dc.date.accessioned2019-07-20T10:41:59Z-
dc.date.available2019-07-20T10:41:59Z-
dc.date.issued2019-
dc.identifier.citationThe 10th National Conference of China Network for Severe Liver Disease (CNSLD), Suzhou, China, 16-18 May 2019-
dc.identifier.urihttp://hdl.handle.net/10722/272421-
dc.description分会场4: 肝胆相照发展论坛--论文交流-
dc.languageeng-
dc.relation.ispartofThe 10th National Conference of China Network for Severe Liver Disease (CNSLD), 2019-
dc.relation.ispartof第十届全国疑难及重症肝病大会-
dc.titleIncidence and clinical characteristics of hepatocellular carcinoma in chronic hepatitis B patients treated for up to 4 years with tenofovir alafenamide or tenofovir disoproxil fumarate in 2 large phase 3 studies.-
dc.title在2项大型3期研究中，使用丙酚替诺福韦 (TAF)或富马酸替诺福韦二吡呋酯(TDF)治疗长达4年的慢性乙型肝炎(CHB)患者中肝细胞癌(HCC)的发生率和临床特征-
dc.typeConference_Paper-
dc.identifier.emailSeto, WKW: wkseto@hku.hk-
dc.identifier.authoritySeto, WKW=rp01659-
dc.identifier.hkuros299506-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats